Home

Leukemia

 

MDS-3: Prognostic factors to hypomethylating agents and intensive chemotherapy in higher risk Myelodysplastic Syndromes
MDS-4 Impact of pre-transplant cytoreductive treatment on high-risk MDS patients undergoing allo-HSCT
Presenting HARMONY leukemia research project results at ELN
CML-5: Prevalence of clinically relevant problems and symptoms in patients with CML
CML-4: Correlation of demographic, disease and therapy factors with toxicity and tolerability of the different TKIs
CML-3: A comparison study of toxicity over time and QoL among all available TKI options
AML-7: The impact of gender on genetic aberrations and clinical outcomes in AML
AML-8: Clinical Meaning and Prognostic Implications of Non-Canonical Non-Type A NPM1 Mutations in Acute Myeloid Leukemia
AML-6: Unravelling the Clinical Impact of Co-mutations in NPM1mut AML
PRESS RELEASE: HARMONY presents new insights in prognosis of AML patients
CML-2: Using Big Data to Map and Identify Optimal Treatment Pathways to Treatment-Free Remission in CML
MDS-2: A retrospective study of patients with Myelodysplastic Syndrome
CML: Delphi Survey Project: Towards a Core Outcome Set for Chronic Myeloid Leukemia (CML)
MPN: Delphi Survey Project: Towards a Core Outcome Set for Myeloproliferative Neoplasms (MPN)
CLL-2: Exploring the occurrence of other malignancies in CLL patients using the HARMONY BigData platform
Big data to improve the care for people with Leukemia
ALL: Delphi Survey Project: Towards a Core Outcome Set for Acute Lymphoblastic Leukemia (ALL)
CML-1: Understanding the clonal hierarchy in Chronic Myeloid Leukemia to help improve patient outcomes
#Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach.
MPN-2: Using big data to improve risk prediction in patients with MPN
CLL: Delphi Survey Project: Towards a Core Outcome Set for Chronic Lymphocytic Leukemia
AML-3: Using big data to shed light on the clinical impact of genomic alterations in sAML/tAML
AML-4: Using big data to confirm the link between MRD and survival in AML
AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients.
1-24   25-48